Banner Image

All Services

Writing & Translation Articles & News

Trethera Announces Appointment of R. Boy

$25/hr Starting at $25



Trethera Announces Appointment of R. Boyd Quinnell to Board of DirectorsTrethera CorporationWed, January 18, 2023 at 7:37 PM GMT+2·4 min readTrethera CorporationLOS ANGELES, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Boyd Quinnell, CPA, MBA, to the Trethera Board of Directors as an independent director. A veteran healthcare executive with over 30 years of experience in executive and financial leadership, Mr. Quinnell will also chair the Board’s Audit Committee.“We are pleased to welcome Boyd to the Trethera Board,” said Dr. Ken Schultz, Chairman and Chief Executive Officer of Trethera. “Boyd’s deep financial expertise in medical technology global businesses with strong regulatory oversight will be invaluable to Trethera as we continue to advance towards first product revenue. His experience commercializing and scaling innovative technologies to improve health outcomes aligns well with our mission, making him an ideal board addition.”“I am delighted to join the Board at this exciting time in Trethera’s growth,” said Mr. Quinnell. “With promising Phase 1 clinical data in oncology and a strong potential to treat a wide array of autoimmune diseases, Trethera is well positioned to execute its mission and clinically advance its lead drug candidate.”Mr. Quinnell, 61, is the former Chief Financial Officer and General Manager for the US division of Biotronik, a medical device company generating over $400M in annual revenue, where he served from 2015 through 2019. Prior to Biotronik, Mr. Quinnell worked for 12 years at increasing levels of responsibility at the world’s largest medical device company, Medtronic, exiting as Controller and Senior Director of Finance. He began his career as a senior consultant at KPMG, one of the Big Four accounting firms. Mr. Quinell received a Bachelor of Arts (BA) degree in business from the University of Hawaii and a Master of Business Administration (MBA) degree from Cornell University. He holds an active certified public accountant (CPA) license. He has served on non-profit boards for the American Heart Association and the charity Food on Foot. Mr. Quinnell remains active in the Los Angeles community in his efforts to alleviate homelessness.

About

$25/hr Ongoing

Download Resume



Trethera Announces Appointment of R. Boyd Quinnell to Board of DirectorsTrethera CorporationWed, January 18, 2023 at 7:37 PM GMT+2·4 min readTrethera CorporationLOS ANGELES, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Boyd Quinnell, CPA, MBA, to the Trethera Board of Directors as an independent director. A veteran healthcare executive with over 30 years of experience in executive and financial leadership, Mr. Quinnell will also chair the Board’s Audit Committee.“We are pleased to welcome Boyd to the Trethera Board,” said Dr. Ken Schultz, Chairman and Chief Executive Officer of Trethera. “Boyd’s deep financial expertise in medical technology global businesses with strong regulatory oversight will be invaluable to Trethera as we continue to advance towards first product revenue. His experience commercializing and scaling innovative technologies to improve health outcomes aligns well with our mission, making him an ideal board addition.”“I am delighted to join the Board at this exciting time in Trethera’s growth,” said Mr. Quinnell. “With promising Phase 1 clinical data in oncology and a strong potential to treat a wide array of autoimmune diseases, Trethera is well positioned to execute its mission and clinically advance its lead drug candidate.”Mr. Quinnell, 61, is the former Chief Financial Officer and General Manager for the US division of Biotronik, a medical device company generating over $400M in annual revenue, where he served from 2015 through 2019. Prior to Biotronik, Mr. Quinnell worked for 12 years at increasing levels of responsibility at the world’s largest medical device company, Medtronic, exiting as Controller and Senior Director of Finance. He began his career as a senior consultant at KPMG, one of the Big Four accounting firms. Mr. Quinell received a Bachelor of Arts (BA) degree in business from the University of Hawaii and a Master of Business Administration (MBA) degree from Cornell University. He holds an active certified public accountant (CPA) license. He has served on non-profit boards for the American Heart Association and the charity Food on Foot. Mr. Quinnell remains active in the Los Angeles community in his efforts to alleviate homelessness.

Skills & Expertise

Administrative AssistantArticle WritingExecutive AssistantFeature WritingHow to ArticlesLifestyle WritingMagazine ArticlesNews Writing

0 Reviews

This Freelancer has not received any feedback.